Embed Size (px)
DESCRIPTION
These are my favorite images that appeared in Pharma Marketing Blog posts made in 2011.
Citation preview
The Year 2011 in Images
These are my favorite images that appeared in Pharma Marketing Blog posts made in 2011.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
FDA carved out “high priority guidances” for which it would publish development timelines. No such timeline, however, has been made public for social media guidelines that were first promised to be published by the end of 2010!
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
FDA Says There are "No simple solutions" to Speed Up Its Regulatory Guidance Process
Posted on January 10, 2011.
FDA’s Guidance Sausage Making Process
Is It Time for Abrams to Leave FDA?
Office of PrescriptionDrug Promotion Director Tom Abrams did not deliver on his promises for social media guidelines. Perhaps it’s time for him to leave the FDA and join PhRMA or a Washington think tank/PR agency.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Is It Time for Abrams to Leave?Posted on February 11, 2011.
AZ Hosts First-Ever Pharma Twitter Chat
Despite dire predictions of “PR failure,” the #rxsave Twitter chat hosted by @AstraZenecaUS was a great success and proof that a pharmaceutical company can indeed host meaningful Twitter chats.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End!
Posted on February 17, 2011.
Phil Mickelson Shills for Enbrel
After Phil became an official Enbrel spokes-person, he had to tone down his endorsement from “I feel stronger and more flexible than I've ever been” to “I like where I am physically and am optimistic about 2011.”
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Phil Mickelson "Opens Up" to Arthritis Today Magazine
Posted on February 21, 2011.
Real Patients Star in Pharma Youtube Videos
Pharma marketers save a bundle repurposing videos for Youtube. They save even more money by hiring real patients to play themselves in these videos! Patients are natural method actors, having actually experienced what they portray. But they are prone to over emote!
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Method Acting for Real Patients Who Play Themselves on
Pharma YouTube ChannelsPosted on February 25, 2011.
Many pharmaceutical marketers are developing mobile Apps. Some are designed for physician use during diagnoses of patients. Are these “medical devices” subject to regulation? Do dis-claimers adequately warn users of limitations? Who checks the software behind the app? Is it accurate? What personal user information is being collected?
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
FDA Promises Still More Guidance! This Time It's Mobile. Janssen's Psoriasis iPhone App May Need It
.Posted on March 16, 2011.
What’s Behind Pharma Mobile Apps?
Drug Development Cost Conflict
How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? “Make no mistake,” said Tufts. “Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its publish-ed research studies.”
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
A New Estimate of Drug Development Cost
Posted on April 23, 2011.
Enough Bullsh*t Already!
The FDA has not issued expected social media guidelines for pharma. But it has commissioned “further studies!
Update: On 27 December 2011, FDA issued guidance on responding to off-label requests, which included social media guidelines.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
FDA's Proposed Web Study Will Further Delay Social Media Guidelines
Posted on April 28, 2011.
FDA Guidance on Responding to Unsolicited Requests for Off-Label Information Via Social Media
Posted on December 28, 2011.
Pharma’s Worst Enemy Is Itself
According to a Bad Ad Program 2010-2011 Year End Report, 125 complaints were deemed worthy of “comprehensive review.” The majority of these (58% or more) came from pharma sources.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Majority of Bad Ad Complaints Submitted by
Pharma "Representatives" Deemed Worthy of "Comprehensive Review" by FDA
Posted on May 13, 2011.
Are PR Agencies Social Media Idiots?
Who should be in charge of pharma’s social media programs – Public Relations agencies or specialized Interactive agencies? The debate began here.
The winner will get mere crumbs from pharma’s total promotional pie.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
PR vs Interactive: Agencies Vie for Pharma Social Media Campaign Crumbs
Posted on May 13, 2011.
Where in the World is Pfizer’s Social Media Playbook?
We’ve looked high and we’ve looked low, but we haven’t found Pfizer’s “ground-breaking internal Social Media Playbook.”
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pfizer, Show Us Your Social Media "Playbook"
Posted on July 14, 2011.
Pharma Followers Trump Content
What’s more important? The number of followers pharma has on Twitter or the content? Pfizer vs. Sanofi is a great case study.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pharma Tweets: Followers Trump Content. Pfizer vs. Sanofi Case Study
Posted on August 5, 2011.
Suspend Your Disbelief in Pharma
A PhRMA blogger urged us NOT to “suspend our disbelief” when viewing the new Planet of the Apes movie. This image depicts what might happen if we don’t follow this advice.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pharma Planet of the Apes!Posted on August 8, 2011.
Flash Mob Attacks Pharma FB Page
Using the same social media tools mobs used to disrupt life in London, online disgruntled patient mobs could be organized to attack pharma Facebook pages. Can this – did this! – happen?
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Social Media "Flash Mobs": Pharma's Worst Facebook Nightmare!
Posted on August 19, 2011.
How Many Patients Are Needed to Yield a Billion Dollars in Sales?
That is a trick question. It depends on the type of drug. For a drug such as Pfizer’s Xalkori, it only takes 9,000 patients!
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
New Big Pharma Economies of Scale: Less Patients Needed to Reach Blockbuster Sales Posted on August 30, 2011.
Say “Rat Poison”
First Boehringer Ingelheim (BI) launched an incredibly odd Youtube video about training parrots to spread the word about BI (“we take this literally,” said a BI tweet). Then, news stories broke about how BI train-ed journalists to “dis” the competition!
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
BI Masters the Art of WOM through Its "Parrots,"
er, SpokespersonsPosted on September 21, 2011.
Pharma’s 2010 DTC Ad Spend
As I have often noted, digital display ad spending is only a minor fraction of pharma's overall DTC advertising budget. In 2010, digital represented only 4.7% of total DTC spending.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Double Dip in DTC Spending Plus 33% Drop in Internet Display Ad Spending!
Posted on October 22, 2011.
Channeling Steve Jobs
There’s a lot of buzz about pharma’s current lack of innovative new products in the “pipeline” and what needs to be done about it. At the same time, many execs are wondering how to be more like Steve Jobs. How about taking this challenge channeled via Steve Jobs?
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Channeling Steve Jobs to Solve Pharma's Innovator's Dilemma
Posted on October 26, 2011.
A Pharma Game I’d Like to See
Boehringer Ingelheim’s long-awaited “Syrum” game may be nothing more than vaporware. When it is available, it probably will not be as popular as “Angry PhRMA,” which mimics real world “knock ‘em out, drag ‘em out” pharma politics!
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pharma & Fun, Not Oxymoronic? Here Comes
Gamification!Posted on October 27, 2011.
Smartass Pfizer Caught
"ChapStick posts weird image on Facebook of a woman, ass in the air, looking for her ChapStick behind a couch,” reported AdWeek. Pfizer’s first reaction: delete all com-plaints posted on its FB page! “Social Media Death Spiral” ensues.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pfizer's Facebook Fiasco: Chapstick Slapstick Ad Uses Woman's Ass as a Prop
Posted on October 27, 2011.
There are No Dead Patient Testimonials
A new study claims that Chantix is “eight times more likely to be linked with a reported case of suicidal behavior or depression than other nicotine replacement products.” You won’t learn that from Chantix patient testimonials on TV – dead patients are silent.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Chantix May Be More Dangerous Than Smoking!
Posted on November 3, 2011.
Let Off-Label Free Speech Free!
Is pharma “uniquely position-ed” to provide doctors with “objective, balanced, and accurate information on important unapproved uses of approved products?”
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Pharma Turns Up the Heat on Off-Label "Free Speech" Chilled by FDA - Implications for Social Media Marketing
Posted on November 8, 2011.
Legal Challenges Thwart Social Media Guidelines
Has issuance of social media & other guidelines for the pharmaceutical industry been delayed by worries about pharma’s overt and implied legal challenges to FDA’s authority to issue such guidance?
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Is the Pharma Industry Responsible for FDA's Delay in Issuing Social Media Guidelines?
Posted on December 2, 2011.
FDA Social Media Guidelines May Be Moot If This Court Decision Holds Up
Posted on December 28, 2011.
Science Takes a Back Seat to Politics
“If I close my eyes...I might think I was in the Bush era,” said Michelle Goldberg, Senior writer for Newsweek. Science takes a back seat to politics as HHS Secretary Sebelius over-rules FDA Commissioner Hamburg on Plan B decision.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
December 7, 2011: A Date Which Will Live in Infamy for Women's Health!
Posted on December 7, 2011.
2011. Pharma Marketing Network. All rights reserved.
Pharma Marketing Blog 2011: The Year in Images
Have a Happy New Year!
